Retention Behaviour of Bupropion Hydrochloride in Reversed Phase Ion Pair LC and Validated Analysis of the Drug in Pharmaceuticals

被引:12
作者
Yeniceli, Duygu [1 ]
Dogrukol-Ak, Dilek [1 ]
机构
[1] Anadolu Univ, Fac Pharm, Dept Analyt Chem, TR-26470 Eskisehir, Turkey
关键词
Column liquid chromatography; Ion-pairing; Pharmaceutical analysis; Method validation; Bupropion hydrochloride; HUMAN-PLASMA; LIQUID-CHROMATOGRAPHY; MAJOR METABOLITES; SEPARATION; COLUMN; HPLC; PHARMACOKINETICS; OPTIMIZATION;
D O I
10.1365/s10337-009-1410-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The chromatographic behaviour of bupropion hydrochloride, a basic drug of pK (a) 7.9, has been investigated under reversed-phase ion-pairing conditions and the results were used to develop a method for analysis of bupropion hydrochloride in pharmaceuticals. Chromatographic separation of bupropion hydrochloride and carbamazepine (used as internal standard) was performed on a C-8 column (150 mm x 4.6 mm i.d., 3.5-mu m particle), with 40:10:50 (v/v) methanol-acetonitrile-phosphate buffer (20 mm, pH 3.0), containing 10 mm 1-heptane sulfonic acid sodium salt (1-HSA), as optimum mobile phase at a flow rate of 1.0 mL min(-1). UV detection was at 254 nm. The fully validated method enables reproducible and selective analysis of bupropion hydrochloride in pharmaceuticals.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 21 条
[1]   Optimization of mobile phase in the separation of β-blockers by HPLC [J].
Basci, NE ;
Temizer, A ;
Bozkurt, A ;
Isimer, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (4-5) :745-750
[2]   High-throughput liquid chromatography-tandem mass spectrometry determination of bupropion and its metabolites in human, mouse and rat plasma using a monolithic column [J].
Borges, V ;
Yang, E ;
Dunn, J ;
Henion, J .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 804 (02) :277-287
[3]   Enantiomeric separation of bupropion enantiomers by electrokinetic chromatography: Quantitative analysis in pharmaceutical formulations [J].
Castro-Puyana, Maria ;
Garcia, M. Angeles ;
Marina, M. Luisa .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 875 (01) :260-265
[4]   Optimization study for the reversed-phase ion-pair liquid chromatographic determination of nicotine in commercial tobacco products [J].
Ciolino, LA ;
Turner, JA ;
McCauley, HA ;
Smallwood, AW ;
Yi, TY .
JOURNAL OF CHROMATOGRAPHY A, 1999, 852 (02) :451-463
[5]   Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MS [J].
Coles, Rebecka ;
Kharasch, Evan D. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 857 (01) :67-75
[6]   DETERMINATION OF BUPROPION AND ITS MAJOR BASIC METABOLITES IN PLASMA BY LIQUID-CHROMATOGRAPHY WITH DUAL-WAVELENGTH ULTRAVIOLET DETECTION [J].
COOPER, TB ;
SUCKOW, RF ;
GLASSMAN, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (08) :1104-1107
[7]   Ruggedness and robustness testing [J].
Dejaegher, Bieke ;
Vander Heyden, Yvan .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1158 (1-2) :138-157
[8]  
ICH Steering Committee International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005, VAL AN PROC TEXT MET
[9]   A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR QUANTITATING BUPROPION IN HUMAN PLASMA OR SERUM [J].
JENNISON, TA ;
BROWN, P ;
CROSSETT, J ;
URRY, FM .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1995, 19 (02) :69-72
[10]   STABILITY OF BUPROPION AND ITS MAJOR METABOLITES IN HUMAN-PLASMA [J].
LAIZURE, SC ;
DEVANE, CL .
THERAPEUTIC DRUG MONITORING, 1985, 7 (04) :447-450